Tumor proliferation associates with greater sensitivity to androgen receptor pathway inhibition in metastatic prostate cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Prostate cancers with high proliferation rates have shorter survival times but when spread has occurred (metastatic), there is increased sensitivity to hormone therapy with abiraterone. .
Fields of Study & Subjects
Prostate Cancer Treatment and Research
Prostate Cancer Diagnosis and Treatment
Cancer
Lipids
and Metabolism
Publication details
- Journal / source
- Journal of Clinical Investigation
- Volume
- 136
- Issue
- 10
- Pages
- e203201
- Publication date
- 31 March 2026
- Language
- EN